glimepiride
Showing 26 - 50 of 128
Type 2 Diabetes Trial (Omarigliptin, Placebo to Omarigliptin, Glimepiride)
Diabetes, Type II Trial in Hanover (Empagliflozin, Glimepiride, Empagliflozin )
Terminated
- Diabetes Mellitus, Type II
- Empagliflozin
- +3 more
-
Hanover, Lower Saxony, GermanyHannover Medical School, University Eye Hospital and CRC Core Fa
Sep 26, 2018
Type 2 Diabetes Trial (Omarigliptin, Matching to Omarigliptin, Glimepiride)
Type 2 Diabetes Trial in Nanjing (Saxagliptin, Glimepiride)
Completed
- Type 2 Diabetes
- Saxagliptin
- Glimepiride
-
Nanjing, Jiangsu, Chinaat Division of Endocrinology, the Affiliated Drum Tower Hospital
Jul 19, 2018
Type 2 Diabetes Trial in China, Korea, Republic of, Taiwan (Dulaglutide, Glimepiride, Placebo as Capsules)
Type 2 Diabetes Trial (Omarigliptin, Matching to omarigliptin, Glimepiride)
Type 2 Diabetes Trial (Ertugliflozin 5 mg, Ertugliflozin 15 mg, Placebo matching ertugliflozin)
Completed
- Type 2 Diabetes Mellitus
- Ertugliflozin 5 mg
- +4 more
- (no location specified)
Nov 13, 2018
Type 2 Diabetes Trial (drug, other, biological)
Completed
- Type 2 Diabetes Mellitus
- Ertugliflozin 5 mg
- +6 more
- (no location specified)
Aug 9, 2018
Diabetes, Type 2 Trial in Worldwide (linagliptin, glimepiride, linagliptin )
Type 2 Diabetes Trial (Sitagliptin phosphate, Comparator: Placebo, Acarbose)
Completed
- Type 2 Diabetes Mellitus
- Sitagliptin phosphate
- +3 more
- (no location specified)
Jul 19, 2018
Type 2 Diabetes Trial (Ertugliflozin 5 mg, Ertugliflozin 15 mg, Placebo for ertugliflozin 5 mg)
Completed
- Type 2 Diabetes Mellitus
- Ertugliflozin 5 mg
- +7 more
- (no location specified)
Aug 15, 2018
Type 2 Diabetes, Inadequate Glycaemic Control Trial in Worldwide (Dapagliflozin, Saxagliptin, Glimepiride)
Completed
- Type 2 Diabetes Mellitus
- Inadequate Glycaemic Control
- Dapagliflozin
- +5 more
-
Hodonin, Czechia
- +172 more
Mar 22, 2019
Diabetes, Diabetes, Type 2 Trial in United States (rosiglitazone, inhaled human insulin, metformin)
Terminated
- Diabetes
- Diabetes Mellitus, Type 2
- rosiglitazone
- +3 more
-
Hueytown, Alabama
- +102 more
Sep 3, 2018
Diabetes, Type 2 Trial in Worldwide (Glimepiride, Metformin, Pioglitazone)
Terminated
- Diabetes Mellitus, Type 2
- Glimepiride
- +9 more
-
Miami, Florida
- +33 more
Sep 25, 2019
Type 2 Diabetes, Hypoglycemia Trial in Colombia (vildagliptin and metformin (combination), glimepiride, Metformin)
Completed
- Type 2 Diabetes
- Hypoglycemia
- vildagliptin and metformin (combination)
- +2 more
-
MedellĂn, Antioquia, Colombia
- +7 more
Apr 13, 2017
Type 2 Diabetes Trial in Chiyoda-Ku (Sitagliptin, Glimepiride)
Completed
- Type 2 Diabetes
- Sitagliptin
- Glimepiride
-
Chiyoda-Ku, Tokyo, JapanJapan Association for Diabetes Education and Care
Mar 3, 2017
Type 2 Diabetes Trial in Korea, Republic of (Nateglinide, Glimepiride)
Completed
- Type 2 Diabetes Mellitus
- Nateglinide
- Glimepiride
-
Ilsan, Kyounggi, Korea, Republic of
- +6 more
May 15, 2017
Type 2 Diabetes Trial (Ertugliflozin 5 mg, Ertugliflozin 10 mg, Placebo to Ertugliflozin)
Completed
- Type 2 Diabetes Mellitus
- Ertugliflozin 5 mg
- +5 more
- (no location specified)
Sep 1, 2017
Diabetes, Diabetes, Type 2 Trial in Adelaide, Neuss (liraglutide, , glimepiride)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- liraglutide
- +2 more
-
Adelaide, South Australia, Australia
- +1 more
Jan 24, 2017
Diabetes, Diabetes, Type 2 Trial in Rochester (liraglutide, , glimepiride)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- liraglutide
- +2 more
-
Rochester, MinnesotaNovo Nordisk Investigational Site
Jan 25, 2017
Diabetes, Diabetes, Type 2 Trial in Worldwide (rosiglitazone, inhaled human insulin, glimepiride)
Terminated
- Diabetes
- Diabetes Mellitus, Type 2
- rosiglitazone
- +2 more
-
St Leonards, New South Wales, Australia
- +25 more
Feb 28, 2017
Diabetes, Type 2 Trial in Vicente Lopez (Dapagliflozin, Glimepiride, Dapagliflozin + Glimepiride)
Completed
- Diabetes Mellitus, Type 2
- Dapagliflozin
- +2 more
-
Vicente Lopez, Buenos Aires, ArgentinaLocal Institution
Oct 14, 2016
Type II Diabetes Trial in Mainz (Vildagliptin, Glimepiride)
Completed
- Type II Diabetes Mellitus
- Vildagliptin
- Glimepiride
-
Mainz, GermanyNovartis Investigative Site
Nov 16, 2016
Diabetes, Diabetes, Type 2 Trial in China, Japan (biphasic insulin aspart 30, metformin, glimepiride)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- biphasic insulin aspart 30
- +3 more
-
Beijing, Beijing, China
- +33 more
Jan 10, 2017